NCT01778946View on ClinicalTrials.gov

Nicotine Treatment of Cognitive Decline in Down Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Down SyndromeMild Cognitive Impairment
Interventions
DRUG

Low Dose Nicotine (7mg)

DRUG

Moderate Dose Nicotine (14mg)

Trial Locations (1)

37212

Vanderbilt Psychiatric Hospital, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT01778946 - Nicotine Treatment of Cognitive Decline in Down Syndrome | Biotech Hunter | Biotech Hunter